Recombinant Anti-DR5 x Anti-FAP Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-DR5 and anti-FAP IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can induce targeted apoptosis by activation of the death receptor. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-DR5 x Human Anti-FAP Bispecific Antibody (scIgG) (SCIGG-H320). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS